Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 675 of 1631 entries
View as:

Phase I Dose Escalation of BAY1143572 in Subjects With Acute Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02345382 Org: User:
Start: 02/19/15 End: 07/30/17 Due: 07/30/18

Long-term Extension From RCC Phase II (11515)

Phase: N/A Priority: Normal
NCT ID: NCT00586495 Org: User:
Start: 12/31/05 End: 07/31/08 Due: 07/31/09

A Study to Learn How Safe the Study Treatment BAY94-9027 is and How it Affects the Body in Previously Treated Children Aged 7 to Less Than 12 Years With Severe Hemophilia A, a Genetic Bleeding Disorder That is Caused by the Lack of a Protein Called Clotting Factor 8 (FVIII) in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT05147662 Org: User:
Start: 03/23/22 End: 05/26/25 Due: 05/26/26

Evaluation of LEVITRA to Advance the Treatment of Erectile Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00664833 Org: User:
Start: 05/31/04 End: 10/31/05 Due: 10/31/06

Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients

Phase: N/A Priority: Normal
NCT ID: NCT01925755 Org: User:
Start: 07/31/13 End: 07/31/15 Due: 07/31/16

Fosrenol Post-marketing Surveillance in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01955876 Org: User:
Start: 10/10/13 End: 08/05/16 Due: 08/05/17

Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)

Phase: N/A Priority: Normal
NCT ID: NCT02610140 Org: User:
Start: 12/03/15 End: 09/06/19 Due: 09/06/20

To Evaluate the Safety, Tolerability, Pulmonary Deposition, Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Inhale in Japanese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD, GOLD II-III)

Phase: N/A Priority: Normal
NCT ID: NCT01072942 Org: User:
Start: 01/31/10 End: 07/31/10 Due: 07/31/11

Sun Protection Factor Assay (SPF Assay 104/2016)

Phase: N/A Priority: Normal
NCT ID: NCT02891057 Org: User:
Start: 08/15/16 End: 08/24/16 Due: 08/24/17

Regorafenib in Subjects With Antiangiogenic-naive and Chemotherapy-refractory Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02465502 Org: User:
Start: 07/21/15 End: 12/11/17 Due: 12/11/18

A Trial to Learn How BAY1817080 Moves Into, Through and Out of the Body and How Safe it is in Healthy Chinese Men

Phase: N/A Priority: Normal
NCT ID: NCT04802343 Org: User:
Start: 04/02/21 End: 10/29/21 Due: 10/29/22

Study to Learn More About the Stomach and Intestine Complaints of Children Aged From 3 to 14 Years

Phase: N/A Priority: Normal
NCT ID: NCT04029376 Org: User:
Start: 04/01/07 End: 10/01/08 Due: 10/01/09

Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01646593 Org: User:
Start: - End: - Due: -

Dose-Finding Trial of Polyethylene Glycol 3350 Laxative Plus Electrolytes for the Treatment of Constipation (Protocol P07515)

Phase: N/A Priority: Normal
NCT ID: NCT01212445 Org: User:
Start: 10/31/10 End: 11/30/11 Due: 11/30/12

A Study to Understand the Usage of an Artificial Intelligence Technology Called DARWEN for Eye Disorders and to Find Out the Factors Influencing Treatment Frequencies in People With nAMD and RVO

Phase: N/A Priority: Normal
NCT ID: NCT06495203 Org: User:
Start: 11/02/23 End: 02/29/24 Due: 02/28/25

Assessment of Vardenafil in Patients With Erectile Dysfunction in Asia

Phase: N/A Priority: Normal
NCT ID: NCT00668135 Org: User:
Start: 03/31/03 End: 04/30/04 Due: 04/30/05

Survey of Prevalence of Loss of Appetite in Subject With Health Disorders

Phase: N/A Priority: Normal
NCT ID: NCT01592149 Org: User:
Start: 05/31/12 End: 01/31/15 Due: 01/31/16

Human Phototoxicity Test

Phase: N/A Priority: Normal
NCT ID: NCT02754102 Org: User:
Start: 05/03/16 End: 05/06/16 Due: 05/06/17

Effect of Concomitant Use of an Antimycotic, an Antibiotic, a Spermicide or Tampons on Pharmacokinetics of Anastrozole and Levonorgestrel Released From Intra-vaginal Ring

Phase: N/A Priority: Normal
NCT ID: NCT02545452 Org: User:
Start: 09/15/15 End: 07/29/16 Due: 07/29/17

A Study to Assess the Safety and Efficacy of Vilaprisan in Japanese Subjects With Uterine Fibroids and Heavy Menstrual Bleeding

Phase: N/A Priority: Normal
NCT ID: NCT03476928 Org: User:
Start: 03/30/18 End: 07/12/21 Due: 07/12/22

Navigant Study- Treatment Patterns in mCRPC (Metastatic Castrate Resistant Prostate Cancer )

Phase: N/A Priority: Normal
NCT ID: NCT02899104 Org: User:
Start: 06/15/17 End: 03/31/19 Due: 03/31/20

Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas Aeruginosa And Other Common Uropathogens

Phase: N/A Priority: Normal
NCT ID: NCT00481689 Org: User:
Start: 05/31/04 End: 09/30/05 Due: 09/30/06

Phase 1 Dose Escalation Study of BAY 1841788 in Japanese Metastatic Castration-resistant Prostate Cancer (mCRPC) Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02363855 Org: User:
Start: 02/23/15 End: 01/18/18 Due: 01/18/19

Vardenafil Treatment Of Erectile Dysfunction In Depressive And Non-Depressive Men

Phase: N/A Priority: Normal
NCT ID: NCT00470873 Org: User:
Start: 01/31/07 End: 02/29/08 Due: 02/28/09

Safety and Tolerability of Oral Polyethylene Glycol (PEG 3350) Solution in Participants With Constipation (MK-8114-003)

Phase: N/A Priority: Normal
NCT ID: NCT01885104 Org: User:
Start: 04/30/13 End: 10/31/13 Due: 10/31/14